Cutting edge: class I presentation of host peptides following HIV infection

J Immunol. 2003 Jul 1;171(1):22-6. doi: 10.4049/jimmunol.171.1.22.

Abstract

Class I MHC molecules bind intracellular peptides for presentation to cytotoxic T lymphocytes. Identification of peptides presented by class I molecules during infection is therefore a priority for detecting and targeting intracellular pathogens. To understand which host-encoded peptides distinguish HIV-infected cells, we have developed a mass spectrometric approach to characterize HLA-B*0702 peptides unique to or up-regulated on infected T cells. In this study, we identify 15 host proteins that are differentially presented on infected human T cells. Peptides with increased expression on HIV-infected cells were derived from multiple categories of cellular proteins including RNA binding proteins and cell cycle regulatory proteins. Therefore, comprehensive analysis of the B*0702 peptide repertoire demonstrates that marked differences in host protein presentation occur after HIV infection.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigen Presentation / immunology*
  • HIV / immunology*
  • HIV Infections / immunology
  • HIV Infections / metabolism
  • HIV Infections / virology
  • HLA-B Antigens / immunology
  • HLA-B Antigens / metabolism*
  • Humans
  • Mass Spectrometry
  • Peptide Fragments / immunology
  • Peptide Fragments / isolation & purification
  • Peptide Fragments / metabolism*
  • Peptide Mapping
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism*
  • T-Lymphocyte Subsets / virology*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • HLA-B Antigens
  • Peptide Fragments